Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The bone marrow provides a specialized and highly supportive microenvironment for tumor growth and development of the associated bone disease. It is a preferred site for breast and prostate cancer bone metastasis and the hematologic malignancy, multiple myeloma. For many years, researchers have focused upon the interactions between tumor cells and the cells directly responsible for bone remodeling, namely osteoclasts and osteoblasts. However, there is ever-increasing evidence for a multitude of ways in which the bone marrow microenvironment can promote disease pathogenesis, including via cancer-associated fibroblasts, the hematopoietic stem cell niche, myeloid-derived suppressor cells, and the sympathetic nervous system. This review discusses the recent advances in our understanding of the contribution of the host microenvironment to the development of cancer-induced bone disease.

Original publication

DOI

10.1158/0008-5472.can-13-2645

Type

Journal article

Journal

Cancer research

Publication Date

05/03/2014

Volume

74

Pages

1625 - 1631

Addresses

Authors' Affiliations: Nuffield Department of Surgical Sciences and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom.

Keywords

Osteoclasts, Osteoblasts, Stem Cells, Bone Marrow, Animals, Humans, Bone Neoplasms, Bone Diseases, Neovascularization, Pathologic, Bone Remodeling, Tumor Microenvironment